Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Public ClinicalTrials.gov record NCT01861249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary Objective: To assess the long term safety and tolerability of SAR339658 Secondary Objective: To assess the long term efficacy of SAR339658
Study identification
- NCT ID
- NCT01861249
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 6 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2013
- Primary completion
- Apr 30, 2014
- Completion
- Mar 31, 2016
- Last update posted
- Jul 12, 2016
2013 – 2016
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840059 | Mission Hills | California | 91345 | — |
| Investigational Site Number 840008 | Miramar | Florida | 33025 | — |
| Investigational Site Number 840048 | Winter Park | Florida | 32789 | — |
| Investigational Site Number 840024 | Mexico | Missouri | 65265 | — |
| Investigational Site Number 840088 | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Ulcerative Colitis trials
Other public records listing Ulcerative Colitis. Sorted by last update posted; newest first. Not a recommendation.
- NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis Active, not recruiting
- NCT06636656: A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis Recruiting
- NCT07619547: Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease Not yet recruiting
- NCT06979336: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) Recruiting
- NCT07665294: Combination CurQD and Vedolizumab in Ulcerative Colitis Not yet recruiting
- NCT07250815: A Study on Infections in Adults With Ulcerative Colitis/Crohn's Disease Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01861249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2016 · Synced Sep 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01861249 live on ClinicalTrials.gov.